InstantGMP, Inc., Developers of the Cutting-Edge Software InstantGMP™ PRO Welcomes New Director of Business Development, Melissa Gammell

InstantGMP, Inc., the developers behind the affordable all-in-one manufacturing and quality software, InstantGMP™ PRO welcomes the newest arrival to the team, Director of Business Development for Pharmaceuticals and Biotech, Melissa Gammell. Ms. Gammell comes from German-based instrumentation company, Satorius, and is ready to make an impact on the industry.

A veteran of the pharmaceutical sales arena, Ms. Gammell brings over 25 years of sales experience with pharmaceutical-related products. Her experience poises her to make an impact on an industry that continues to use paper-based documentation despite being at the forefront of innovative therapies.

Ms. Gammell recognizes the uniqueness and applicability of InstantGMP™ PRO for multiple types of pharmaceutical and biotech companies. InstantGMP™ PRO is perfect for companies coming out of phase II clinical trials, those producing pilot batches, distributors, and manufacturers. It is especially useful to companies because of the integrated modules that improve management of inventory, electronic batch records, documents, and quality assurance activities. InstantGMP™ PRO showcases its compliance with 21 CFR Part 211 Good Manufacturing Practices regulations, GAMP 5, and the FDA’s general principles of software validation.

Ms. Gammell looks to help companies ramp-up production, improve quality and consistency, decrease the time between batches, and make the transition to an electronic recordkeeping system. Get in touch to learn more about the benefits and features of InstantGMP™ PRO.

About InstantGMP, Inc.

InstantGMP, Inc. is the brain-child of pharmaceutical veteran Dr. Richard Soltero and is the creator of the affordable all-in-one manufacturing and quality software, InstantGMP™. InstantGMP™ organizes and manages production processes and benefits companies by improving batch quality across several industries: biopharmaceuticals, biotech, cannabis, CBD, cosmetics, dietary supplements, e-liquids, hemp, herbal products, kratom, and medical devices.